Pages that link to "Q38480437"
Jump to navigation
Jump to search
The following pages link to Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers (Q38480437):
Displaying 12 items.
- Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? (Q28078539) (← links)
- 5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas. (Q36569563) (← links)
- Glioma: experimental models and reality (Q37596796) (← links)
- Biological Significance of Mutant Isocitrate Dehydrogenase 1 and 2 in Gliomagenesis (Q38767308) (← links)
- Gliomatosis cerebri: A consensus summary report from the First International Gliomatosis cerebri Group Meeting, March 26-27, 2015, Paris, France (Q38910830) (← links)
- Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas. (Q48841420) (← links)
- Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line. (Q55457135) (← links)
- Association between mutant IDHs and tumorigenesis in gliomas. (Q55457331) (← links)
- p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors (Q60215147) (← links)
- Understanding cognitive functioning in glioma patients: The relevance of IDH-mutation status and functional connectivity (Q64099477) (← links)
- Effect of marital status on survival in glioblastoma multiforme by demographics, education, economic factors, and insurance status (Q90227590) (← links)
- SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis (Q98943923) (← links)